Beam Therapeutics Inc.

NASDAQ: BEAM · Real-Time Price · USD
17.64
0.12 (0.68%)
At close: Aug 14, 2025, 3:59 PM
17.70
0.34%
Pre-market: Aug 15, 2025, 06:17 AM EDT

Beam Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-376.74M -132.53M -289.09M -370.64M
Depreciation & Amortization
21.93M 20.01M 14.15M 7.45M
Stock-Based Compensation
120.66M 98.65M 84.32M 43.57M
Other Working Capital
-112.03M -108.88M 249.25M 110.44M
Other Non-Cash Items
n/a -18.87M -38.48M 158.86M
Deferred Income Tax
n/a n/a n/a -16.77M
Change in Working Capital
-110.22M -116.45M 251.63M 111.25M
Operating Cash Flow
-347.25M -149.19M 22.53M -66.27M
Capital Expenditures
-8.95M -33.73M -48.95M -46.81M
Cash Acquisitions
n/a n/a 412.38M 620K
Purchase of Investments
-486.44M -984.34M -1.62B -777.22M
Sales Maturities Of Investments
680.39M 1.09B 1.2B 529.27M
Other Investing Acitivies
n/a n/a -412.38M -247.95M
Investing Cash Flow
185.01M 71.84M -461.34M -294.14M
Debt Repayment
-485K -2.25M -2.29M -2.12M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
8.22M 8.53M 5.62M 810K
Financial Cash Flow
7.74M 276.45M 111.59M 756.14M
Net Cash Flow
-154.5M 199.09M -327.22M 395.73M
Free Cash Flow
-356.19M -182.93M -26.42M -113.08M